1. Agid, Y., Ruberg, M., Raisman, R. et al. (1990) The biochemistry of Parkinson’s disease. In Parkinson’s Disease (ed. G.M. Stern ), Chapman and Hall Medical, London, pp. 99–126.
2. Allen, S.J., Dawbarn, D., MacGowan, S.H. et al. (1990) Quantitative morphometric analysis of basal forebrain neurons expressing 13-nerve growth factor receptors in normal and Alzheimer’s disease brains. Dementia, 1, 125–37.
3. Barnes, J.M., Costall, B., Coughlan, J. et al. (1990) The effects of Ondansetron, a 5HT3 receptor antagonist, on cognition in rodents and primates. Pharmacol. Biochem. Behay., 35, 955–62.
4. Baron, J.A. (1986) Cigarette smoking and Parkinson’s disease. Neurology, 36, 1490–6.
5. Beal, M.F., Clevens, R.A., Chatta, G.K. et al. (1988) Galanin-like immunoreactivity is unchanged in Alzheimer’s disease and Parkinson’s disease dementia cerebral cortex. J. Neurochem., 21, 1935–41.